Daniel O'Day
Insider · Gilead Sciences, Inc. (GILD)
planned sales: $26,426,837
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 4, 2026 | Planned sale 10b5-1 plan | 112,429 | — | $18,828,485 | SEC |
| October 30, 2026 | Planned sale 10b5-1 plan | 45,881 | — | $7,598,352 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
